China East China is a state-owned enterprise. Huadong Pharmaceutical Co., Ltd., stock code 000963, is one of China's top 500 companies. It is mainly engaged in the production and sales of antibiotics, Chinese patent medicines, chemical synthetic drugs, genetic engineering drugs, as well as the wholesale and retail distribution business of Chinese and Western medicines, Chinese medicinal materials, medical devices, etc. It is a It is a large-scale comprehensive pharmaceutical listed company integrating pharmaceutical research and development, pharmaceutical industry, pharmaceutical distribution and pharmaceutical logistics.
Scale of Sino-American Huadong
Huadong Pharmaceutical Group has more than 20 member companies, mainly listed companies Huadong Pharmaceutical Co., Ltd., Hangzhou Sino-American Huadong Pharmaceutical Co., Ltd., and Hangzhou Jiuyuan Gene Engineering Co., Ltd., Hangzhou MSD Pharmaceutical Co., Ltd., Zhejiang Huayi Pharmaceutical Co., Ltd., Esteve Huayi Pharmaceutical Co., Ltd., Hangzhou Zhu Yangxin Pharmaceutical Co., Ltd., Hangzhou Huadong Pharmaceutical Group Kangrun Pharmaceutical Co., Ltd., etc.
As of the end of 2008, it had more than 5,000 employees and total assets of 5.223 billion yuan. In 2008, the sales revenue was 8.482 billion yuan, the total profit was 550 million yuan, and the total tax paid was 393 million yuan. It has 31 patents, including 30 invention patents.